398 related articles for article (PubMed ID: 37396784)
1. N-methyl-D-aspartate receptor hypofunction as a potential contributor to the progression and manifestation of many neurological disorders.
Dong B; Yue Y; Dong H; Wang Y
Front Mol Neurosci; 2023; 16():1174738. PubMed ID: 37396784
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.
Snyder MA; Gao WJ
Schizophr Res; 2020 Mar; 217():60-70. PubMed ID: 30979669
[TBL] [Abstract][Full Text] [Related]
3. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
Geoffroy C; Paoletti P; Mony L
J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of NMDA receptor regulation.
Mony L; Paoletti P
Curr Opin Neurobiol; 2023 Dec; 83():102815. PubMed ID: 37988826
[TBL] [Abstract][Full Text] [Related]
5. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
6. The origin of NMDA receptor hypofunction in schizophrenia.
Nakazawa K; Sapkota K
Pharmacol Ther; 2020 Jan; 205():107426. PubMed ID: 31629007
[TBL] [Abstract][Full Text] [Related]
7. Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia.
Wu Q; Huang J; Wu R
Front Neurosci; 2021; 15():641047. PubMed ID: 33912003
[TBL] [Abstract][Full Text] [Related]
8. Tonic NMDA Receptor Currents in the Brain: Regulation and Cognitive Functions.
Kim H; Choi S; Lee E; Koh W; Lee CJ
Biol Psychiatry; 2024 Mar; ():. PubMed ID: 38490367
[TBL] [Abstract][Full Text] [Related]
9. Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?
Bygrave AM; Kilonzo K; Kullmann DM; Bannerman DM; Kätzel D
Front Psychiatry; 2019; 10():835. PubMed ID: 31824347
[TBL] [Abstract][Full Text] [Related]
10. Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2
Chung C; Ha S; Kang H; Lee J; Um SM; Yan H; Yoo YE; Yoo T; Jung H; Lee D; Lee E; Lee S; Kim J; Kim R; Kwon Y; Kim W; Kim H; Duffney L; Kim D; Mah W; Won H; Mo S; Kim JY; Lim CS; Kaang BK; Boeckers TM; Chung Y; Kim H; Jiang YH; Kim E
Biol Psychiatry; 2019 Apr; 85(7):534-543. PubMed ID: 30466882
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.
Pei JC; Hung WL; Lin BX; Shih MH; Lu LY; Luo DZ; Tai HC; Studer V; Min MY; Lai WS
J Psychopharmacol; 2019 Oct; 33(10):1288-1302. PubMed ID: 31294644
[TBL] [Abstract][Full Text] [Related]
12. NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia.
Snyder MA; Gao WJ
Front Cell Neurosci; 2013; 7():31. PubMed ID: 23543703
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J
Front Pharmacol; 2014 Jan; 4():169. PubMed ID: 24427139
[TBL] [Abstract][Full Text] [Related]
14. Hystero-epilepsy in the Tuesday Lessons and NMDA receptor function: A hypothesis for dissociative disorder.
Komagamine T; Kokubun N; Hirata K
Med Hypotheses; 2021 May; 150():110567. PubMed ID: 33799161
[TBL] [Abstract][Full Text] [Related]
15. Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.
Yao L; Zhou Q
Neural Plast; 2017; 2017():2875904. PubMed ID: 28163934
[TBL] [Abstract][Full Text] [Related]
16. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia.
Gulchina Y; Xu SJ; Snyder MA; Elefant F; Gao WJ
J Neurochem; 2017 Nov; 143(3):320-333. PubMed ID: 28628228
[TBL] [Abstract][Full Text] [Related]
18. Transient neuroinflammation following surgery contributes to long-lasting cognitive decline in elderly rats via dysfunction of synaptic NMDA receptor.
Chen B; Qin G; Xiao J; Deng X; Lin A; Liu H
J Neuroinflammation; 2022 Jul; 19(1):181. PubMed ID: 35831873
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
Tang W; Liu D; Traynelis SF; Yuan H
Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Anti-NMDAR Antibody Disinhibits Cortical Neuronal Networks through Dysfunction of Inhibitory Neuron Output.
Andrzejak E; Rabinovitch E; Kreye J; Prüss H; Rosenmund C; Ziv NE; Garner CC; Ackermann F
J Neurosci; 2022 Apr; 42(15):3253-3270. PubMed ID: 35241491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
